Skip to main content
. 2018 May 15;9(4):214–218. doi: 10.1159/000489055

Fig. 3.

Fig. 3

Phase determination of the compound heterozygous mutations, c.3233+1G>T and c.3139-1G>C. Top lines are amino acid number and sequence of the WRN protein and nucleotide number of coding exon 25 (exon 26). Sequence results of patient DNA and each of 2 alleles are shown with locations of pathogenic variants in red squares.